AI assistant
Sending…
ARVINAS, INC. — Director's Dealing 2021
Aug 16, 2021
32625_dirs_2021-08-16_d7bbd181-0334-4950-91b0-6347bed782b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ARVINAS, INC. (ARVN)
CIK: 0001655759
Period of Report: 2021-08-12
Reporting Person: Peck Ronald (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-12 | Common Stock | M | 4011 | — | Acquired | 6765 | Direct |
| 2021-08-12 | Common Stock | S | 1363 | $90.5351 | Disposed | 5402 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-12 | Restricted Stock Units | $ | M | 4011 | Disposed | Common Stock (4011) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
F2: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
F3: On July 29, 2019, the reporting person was granted 16,041 Restricted Stock Units, vesting in four equal annual installments beginning July 29, 2020.
More from ARVINAS, INC.
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 1
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3